STAT3 and breast cancer: Moreover, IL-6 or leptin can increase procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) expression in breast cancer cells through the activation of the JAK/STAT3 and the AKT signalling pathway.